Pharma Business Hub / Pharmacy Business Update & News / Gym Business / Fitness Business / Pharmacy Trends / Pharmacy Technology / B2B pharmacy / Pharmacy Distributors

Latest Post

• EMA Licensing Made Easy: A Wholesaler’s 2025 Checklist

  Why EMA Compliance Just Got More Critical With the European Medicines Agency (EMA) tightening regulations in 2025, pharmaceutical wholesalers must ensure full compliance to avoid costly delays, fines, or even license suspensions. The updated Good Distribution Practice (GDP) guidelines introduce stricter requirements for traceability, quality control, and cold chain management. This step-by-step checklist simplifies the…

  read more >>: EMA Licensing Made Easy: A Wholesaler’s 2025 Checklist

• FDA’s 2025 New Rules That Could Shut You Down

  FDA’s 2025 new rules. If you’re in pharmaceutical distribution, you already know the FDA doesn’t send a friendly memo before turning your compliance strategy upside down. And with the 2025 FDA changes for pharmaceutical distributors rolling in, the stakes just got higher. I remember the first time an FDA audit caught one of my clients…

  read more >>: FDA’s 2025 New Rules That Could Shut You Down

• Post-COVID Realities: 3 Distribution Models That Are Dying (And 3 Thriving)

  3 Distribution Models That Are Dying, The COVID-19 pandemic permanently reshaped pharmaceutical distribution, accelerating some models to obsolescence while propelling others to new heights. As the industry adapts to post-pandemic realities, companies must rethink their distribution strategies or risk falling behind. In this article, we examine:✔ 3 outdated distribution models losing relevance✔ 3 innovative approaches…

  read more >>: Post-COVID Realities: 3 Distribution Models That Are Dying (And 3 Thriving)

• How US-China Tensions Are Forcing Pharma to Rethink Global Supply Chains

  The pharmaceutical industry is undergoing a seismic shift. Geopolitical tensions between the United States and China are not only straining diplomacy but also disrupting long-standing global supply chains. With China responsible for 40% of global API (Active Pharmaceutical Ingredient) production and the U.S. pushing for domestic manufacturing, pharma companies are urgently diversifying suppliers, relocating production,…

  read more >>: How US-China Tensions Are Forcing Pharma to Rethink Global Supply Chains

• Beyond India & China: 5 Emerging Pharma Markets With 20%+ Growth Potential

  The global pharmaceutical industry is expanding rapidly, with India and China dominating headlines as key growth drivers. However, several emerging pharma markets are poised for explosive growth—offering 20% or higher annual expansion in the coming years. For investors, pharmaceutical companies, and healthcare stakeholders, these high-growth regions present untapped opportunities for market expansion, cost-efficient manufacturing, and…

  read more >>: Beyond India & China: 5 Emerging Pharma Markets With 20%+ Growth Potential

• The WMS Features Cutting Pharma Warehouse Costs by 40% in 2025

  Cutting Pharma Warehouse Costs, Pharmaceutical warehouses face skyrocketing operational costs, with labor, compliance, and inventory waste consuming 25-35% of revenue. But next-generation Warehouse Management Systems (WMS) are slashing these expenses through automation, AI, and smart inventory control. This data-driven guide reveals:✔ 7 game-changing WMS features delivering 40%+ cost reductions✔ Real-world case studies from top pharma…

  read more >>: The WMS Features Cutting Pharma Warehouse Costs by 40% in 2025

• Pharma Inventory Software Buyer’s Guide: 7 Must-Check Features for 2025

  Pharma Inventory Software, Choosing the right pharmaceutical inventory management system can mean the difference between regulatory compliance and costly recalls, efficient operations and supply chain chaos. With DSCSA enforcement tightening and cold chain demands growing, your 2025 software needs more advanced capabilities than ever. This data-driven buyer’s guide reveals:✔ 7 non-negotiable features for modern pharma…

  read more >>: Pharma Inventory Software Buyer’s Guide: 7 Must-Check Features for 2025

• M&A in Pharma Distribution: What You Need to Know in 2025

  M&A in Pharma Distribution, The pharmaceutical distribution sector is undergoing unprecedented consolidation, with global M&A deal values expected to exceed $150 billion in 2025. For distributors, manufacturers, and investors, understanding the latest trends, regulations, and strategies is critical to capitalizing on this wave. This guide covers:✔ Key drivers behind 2025’s M&A surge✔ The hottest acquisition…

  read more >>: M&A in Pharma Distribution: What You Need to Know in 2025

• SAP vs Oracle: Which Pharma Supply Chain Giant Wins in 2025?

  SAP vs Oracle, The battle for dominance in pharmaceutical supply chain technology is heating up, with SAP and Oracle rolling out major 2025 updates tailored for drug manufacturers and distributors. Choosing the right platform can mean the difference between flawless DSCSA compliance and costly regulatory failures. This data-driven comparison breaks down:✔ 2025’s must-have pharma supply…

  read more >>: SAP vs Oracle: Which Pharma Supply Chain Giant Wins in 2025?